Vita Enamic (hybrid dental ceramic)
OtherVita Enamic (hybrid dental ceramic) are provided as blocks to be milled using Computer aided design/Computer aided manufacturer (CAD/CAM) technology,
Other names: hybrid, resin nanoceramic
NCT Number: NCT02931903
The aim of this study is to assess the effect of the newly introduced (hybrid dental ceramic) superstructure materials, Vita Enamic versus IPS Emax on implant stability, patient satisfaction and crestal bone loss.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
This study will be conducted on patients requiring single implant replacement in the maxillary premolar area, admitted to the Outpatient Clinic of Fixed Prosthodontics Department, Faculty of Oral and Dental medicine, Cairo University.
After a period of healing of 6 months, an implant abutment of accurate diameter and angulation will be placed to fit precisely into the internal hex of the fixture after removal of the cover screw. The platform matched abutment will be then secured into its final position using the abutment screw. Alginate impression will be taken and poured into dental stone. Using the impression transfers, impressions with polyvinylsiloxane are taken. After taking the impressions, the Impression transfers are removed and fixed to the implant replica.
Surgeons' assistants will be asked to open the sealed envelope containing the information regarding the crown placement. The impressions will be sent to dental laboratory with the result of the sealed envelope, for preparation of the future crowns, either vita enamic crowns or Ips e max crowns.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients > 18 yrs. Patients with missing teeth in the maxillary premolar region. Absence of any pathological condition in the recipient site.
Stabilization phase will be performed including:
Patients who are cooperative, motivated, and hygiene conscious. Patients should have adequate ridge width (>5mm).
Exclusion criteria
Patients unable to undergo minor surgical procedure. Patients with history of drug abuse or metabolic drugs. Patients with history of psychiatric disorder. Patients with insufficient bone. Patients with insufficient vertical inter-arch space, upon centric occlusion, to accommodate the available restorative components.
Patients with any systemic condition that may contraindicate implant therapy. Patients that may have any habits that may jeopardize the osseo-integration process, such as heavy smoking and alcoholism.
Patients with para-functional habits that produce overload on the implant such as bruxism and clenching.
Vita Enamic (hybrid dental ceramic) are provided as blocks to be milled using Computer aided design/Computer aided manufacturer (CAD/CAM) technology,
Other names: hybrid, resin nanoceramic
All ceramic crowns (Lithium disilicate glass ceramic) milled by Computer aided design/Computer aided manufacturer (CAD/CAM) technology
Other names: Emax CAD, IPS Emax
Time frame: 12 months
Implant stability and success could be affected by crestal bone loss, if the implant is stable therefore high survival rate
Time frame: 12 months
Crestal bone loss will be measured using a Cone Beam Computed tomography to measure the amount of bone resorbed from start date, and follow up for one year
Time frame: 12 months
Bleeding index, probing depth and gingival index
Time frame: 12 months
Patients will be asked to answer a questionnaire to know whether the procedure was not satisfied, accepted, or highly satisfied
Cairo University
Other
The Effect of Lithium Disilicate Glass-ceramic (IPS Emax) Versus Hybrid Ceramic (Vita Enamic) Superstructure Materials on Implant Stability in Implant Supported Restorations
Acronym: RCT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06433700
Arthritis Knee, Bariatric Surgery Candidate
Copenhagen, Denmark
View Trial DetailsNCT06114069
Pathologic Processes, Pathological Conditions, Signs and Symptoms
Al Mansurah, DK, Egypt
View Trial DetailsNCT04773873
Pathologic Processes, Pathological Conditions, Signs and Symptoms
Geneva, Switzerland
View Trial DetailsNCT04244929
Pathologic Processes, Pathological Conditions, Signs and Symptoms
Bologna, Italy
View Trial Details